GT Medical Technologies Announces $16 Million Financing to Expand Availability of Targeted Therapy for Patients with Recurrent Brain Tumors

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2IWnw1A
via IFTTT